Frontiers in Immunology · 2018 · 15 citations · 44 references
Life SciencesImmunologyMolecular BiologyCell SignalingOncogenesSignal TransductionB Cell ActivationB Cell BiologyB Cell Receptor SignalingBcl-2 Family ProteinsLymphocyte ActivationT Cell ActivationAntigen Receptor SignalingB Cell Antigen Receptor StructureB Cell Receptor Signaling ComplexesFusion Driver MutationsLymphocyte Activation SignalingNf-κb SignalingOncogenic Driver Mutations
Assembly of the CARD11/CARMA1-BCL10-MALT1 (CBM) signaling complex upon T or B cell antigen receptor (TCR or BCR) engagement drives lymphocyte activation. Recruitment of pre-assembled BCL10-MALT1 complexes to CARD11 fosters activation of the MALT1 protease and canonical NF-B signaling. Structural data and in vitro assays have suggested that CARD11 acts as a seed that nucleates the assembly of BCL10 filaments, but the relevance of these findings for CBM complex assembly in cell remains unresolved. To uncouple cellular CARD11 recruitment of BCL10 and BCL10 filament assembly, we generated a BCL10-CARD11 fusion protein that links the C-terminus of BCL10 to the N-terminus of CARD11. When stably expressed in CARD11 KO Jurkat T cells, the BCL10-CARD11 fusion induced constitutive MALT1 activation. Furthermore, in CARD11 KO BJAB B cells, BCL10-CARD11 promoted constitutive NF-B activation to a similar extent as CARD11 containing oncogenic driver mutations. Using structure-guided destructive mutations in the CARD11-BCL10 (CARD11 R35A) or BCL10-BCL10 (BCL10 R42E) interfaces, we demonstrate that chronic activation by the BCL10-CARD11 fusion protein was independent of the CARD11 CARD. However, activation strictly relied upon the ability of the BCL10 CARD to form oligomers. Thus, by combining distinct CARD mutations in the context of constitutively active BCL10-CARD11 fusion proteins, we provide evidence that BCL10-MALT1 recruitment to CARD11 and BCL10 filament formation are interconnected processes, which bridge the CARD11 seed to downstream pathways in lymphocytes.
44
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong, F. Ann Ran, David Cox et al. · Science · 2013 · 15.7K citations
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
Oncogenic <i>CARD11</i> Mutations in Human Diffuse Large B Cell Lymphoma
Georg Lenz, R. Eric Davis, Vu N. Ngo et al. · Science · 2008 · 875 citations